134 related articles for article (PubMed ID: 38140914)
1. A pilot recruitment strategy to enhance ethical and equitable access to Covid-19 pediatric vaccine trials.
Muller WJ; Jhaveri R; Heald-Sargent T; Macy ML; Heard-Garris N; Shah S; Paquette E
Clin Trials; 2024 Jun; 21(3):390-396. PubMed ID: 38140914
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges.
Cooper DM; Afghani B; Byington CL; Cunningham CK; Golub S; Lu KD; Radom-Aizik S; Ross LF; Singh J; Smoyer WE; Lucas CT; Tunney J; Zaldivar F; Ulloa ER
Pediatr Res; 2021 Nov; 90(5):966-970. PubMed ID: 33627824
[TBL] [Abstract][Full Text] [Related]
3. Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
Andrasik MP; Broder GB; Wallace SE; Chaturvedi R; Michael NL; Bock S; Beyrer C; Oseso L; Aina J; Lucas J; Wilson DR; Kublin JG; Mensah GA
PLoS One; 2021; 16(10):e0258858. PubMed ID: 34665829
[TBL] [Abstract][Full Text] [Related]
4. Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit.
Argyropoulos CD; Leckler J; Salmanton-García J; Constantinou M; Alexandrou A; Themistocleous S; Noula E; Shiamakkides G; Nearchou A; Stewart FA; Albus K; Koniordou M; Kopsidas I; Spivak O; Hellemans M; Hendrickx G; Davis RJ; Azzini AM; Simon PV; Carcas-Sansuan AJ; Askling HH; Vene S; Prellezo JB; Álvarez-Barco E; Macken AJ; Di Marzo R; Luís C; Olesen OF; Frias Iniesta JA; Barta I; Tóth K; Akova M; Bonten MMJ; Cohen-Kandli M; Cox RJ; Součková L; Husa P; Jancoriene L; Launay O; Lundgren J; Mallon P; Armeftis C; Marques L; Naucler P; Ochando J; Tacconelli E; van Damme P; Zaoutis T; Hofstraat S; Bruijning-Verhagen P; Zeitlinger M; Cornely OA; Pana ZD
JMIR Public Health Surveill; 2023 Apr; 9():e44491. PubMed ID: 36878478
[TBL] [Abstract][Full Text] [Related]
5. Rapid Transition to Telehealth and the Digital Divide: Implications for Primary Care Access and Equity in a Post-COVID Era.
Chang JE; Lai AY; Gupta A; Nguyen AM; Berry CA; Shelley DR
Milbank Q; 2021 Jun; 99(2):340-368. PubMed ID: 34075622
[TBL] [Abstract][Full Text] [Related]
6. Equitable COVID-19 Vaccination for Hispanics in the United States: A Success Story from California Border Communities.
Martinez ME; Nodora JN; McDaniels-Davidson C; Crespo NC; Edward AA
Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010795
[TBL] [Abstract][Full Text] [Related]
7. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
Eccleston-Turner M; Upton H
Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
[TBL] [Abstract][Full Text] [Related]
8. A Community Partnered Approach to Promoting COVID-19 Vaccine Equity.
Scott T; Gutschow B; Ragavan MI; Ho K; Massart M; Ripper L; Muthama V; Miller E; Bey J; Abernathy RP
Health Promot Pract; 2021 Nov; 22(6):758-760. PubMed ID: 34311592
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Racial, Ethnic, and Geographic Location Diversity of Participants Enrolled in Clinic-Based vs 2 Remote COVID-19 Clinical Trials.
Stewart J; Krows ML; Schaafsma TT; Heller KB; Brown ER; Boonyaratanakornkit J; Brown CE; Leingang H; Liou C; Bershteyn A; Schwartz MD; Agrawal V; Friedman-Klabanoff D; Eustace S; Stankiewicz Karita HC; Paasche-Orlow MK; Kissinger P; Hosek SG; Chu HY; Celum C; Baeten JM; Wald A; Johnston C; Barnabas RV
JAMA Netw Open; 2022 Feb; 5(2):e2148325. PubMed ID: 35157053
[TBL] [Abstract][Full Text] [Related]
10. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
Rid A; Lipsitch M; Miller FG
JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
[No Abstract] [Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora.
Xu Q; McMann TJ; Li J; Wenzel C; Mackey TK
Trials; 2023 Dec; 24(1):790. PubMed ID: 38053216
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Vaccine Decision-making Factors in Racial and Ethnic Minority Communities in Los Angeles, California.
Carson SL; Casillas A; Castellon-Lopez Y; Mansfield LN; Morris D; Barron J; Ntekume E; Landovitz R; Vassar SD; Norris KC; Dubinett SM; Garrison NA; Brown AF
JAMA Netw Open; 2021 Sep; 4(9):e2127582. PubMed ID: 34591103
[TBL] [Abstract][Full Text] [Related]
14. Will access to COVID-19 vaccine in Aotearoa be equitable for priority populations?
Whitehead J; Scott N; Carr PA; Lawrenson R
N Z Med J; 2021 May; 134(1535):25-35. PubMed ID: 34012138
[TBL] [Abstract][Full Text] [Related]
15. Enacting Relational Public Health: Federally Qualified Health Centers During the COVID-19 Pandemic.
Pacia D; Crane J; Neuhaus C; Berlinger N; Fabi R
J Law Med Ethics; 2024; 52(1):34-40. PubMed ID: 38818603
[TBL] [Abstract][Full Text] [Related]
16. Socialized and traumatized: Pharmacists, underserved patients, and the COVID-19 vaccine.
Riley AC; Campbell H; Butler L; Wisseh C; Nonyel NP; Shaw TE
J Am Pharm Assoc (2003); 2021; 61(6):e2-e5. PubMed ID: 34147364
[TBL] [Abstract][Full Text] [Related]
17. Diversity and inclusion in clinical trials: Evolution throughout the development of an mRNA COVID-19 vaccine.
Hill J; Montross D; Ivarsson M
Front Public Health; 2023; 11():1113003. PubMed ID: 37181705
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
Hunter CM; Chou WS; Webb Hooper M
Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
[TBL] [Abstract][Full Text] [Related]
20. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond.
Sethi S; Kumar A; Mandal A; Shaikh M; Hall CA; Kirk JMW; Moss P; Brookes MJ; Basu S
Trials; 2021 Apr; 22(1):296. PubMed ID: 33879208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
